Stefania Pittaluga

48PUBLICATIONS
587CO-AUTHORS
Immunogenetics (incl. genetic immunology)Haematological tumoursMolecular targetsLiquid biopsiesSocial program evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jun 08, 2026
GPR15-guided CD8+ T regulatory cells control intestinal inflammation.

|Apr 23, 2026
DNA methylation-based classification of hematolymphoid neoplasms.

|Mar 04, 2026
A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma.

Max J Gordon, Milos D Miljkovic, Paige Milhon

|Dec 02, 2025
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study.

Andrew L Feldman, Surendra Dasari, Lisa M Rimsza

|Oct 31, 2025
Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma.

Max J Gordon, Rahul Lakhotia, Stefania Pittaluga

|Aug 05, 2025
Characteristics and outcomes of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome.

Ramya Ramaswami, Kathryn Lurain, Mark N Polizzotto

Pageof 8

Frequent Collaborators

19 joint publications

Elaine S Jaffe

7 joint publications

Luigi D Notarangelo

7 joint publications

Grace Smith

6 joint publications

Elias Campo